PMID- 21087427 OWN - NLM STAT- MEDLINE DCOM- 20110304 LR - 20110505 IS - 1747-0803 (Electronic) IS - 1747-079X (Linking) VI - 5 IP - 5 DP - 2010 Sep-Oct TI - Arrhythmia recurrence in adult patients with single ventricle physiology following surgical Fontan conversion. PG - 430-4 LID - 10.1111/j.1747-0803.2010.00443.x [doi] AB - OBJECTIVES: To evaluate the incidence of atrial tachy-arrhythmia (AT) recurrence following conversion from right atrial-pulmonary artery (RA-PA) Fontan to total cavopulmonary connection (TCPC) in adults. BACKGROUND: AT is a recognized sequel of Fontan palliation, especially in RA-PA Fontans, and is associated with significant morbidity. While catheter ablation achieves fairly reliable short-term success with low morbidity, conversion to TCPC with arrhythmia surgery is a highly effective treatment option for the classical Fontan patients with incessant AT. METHODS: Single center retrospective review. RESULTS: Twenty-seven adults underwent Fontan conversion from RA-PA to TCPC, mostly for AT indications (n = 24). Nine (33%) underwent conversion to a lateral tunnel (LT) and 18 (67%) to an extracardiac (EC) Fontan. Two patients died <30 days post-operatively. Both had liver failure and had been turned down for cardiac/liver transplantation. In-hospital complications occurred in 15/27 patients (55%), including recurrence of AT requiring cardioversion in six patients (22%) and persistent pleural effusions in 4 (15%). Mean follow-up was 4.2 years (range 3 months-14 years). Functional capacity improved from mean New York Heart Association (NYHA) class 1.8 pre-conversion to 1.2 post-conversion (P= 0.008). Twenty-one patients had concomitant arrhythmia surgery (MAZE in 12 patients with IART and Cox-MAZE in nine patients with A-Fib +/- IART). Of these, 3/21 (14%) had AT recurrence >3 months following conversion. CONCLUSIONS: Conversion from RA-PA Fontan to TCPC, with arrhythmia surgery, decreases AT recurrence and improves functional capacity. The risk of peri-operative mortality is highest in patients with cirrhosis. AT recurred in 14% of patients. FAU - Aboulhosn, Jamil AU - Aboulhosn J AD - Ahmanson/UCLA Adult Congenital Heart Disease Center, UCLA Medical Center, BH-307 CHS, 650 Charles Young Drive South, Los Angeles, CA, USA. jaboulhosn@mednet.ucla.edu FAU - Williams, Ryan AU - Williams R FAU - Shivkumar, Kalyanam AU - Shivkumar K FAU - Barkowski, Rakhi AU - Barkowski R FAU - Plunkett, Mark AU - Plunkett M FAU - Miner, Pamela AU - Miner P FAU - Houser, Linda AU - Houser L FAU - Laks, Hillel AU - Laks H FAU - Reemtsen, Brian AU - Reemtsen B FAU - Shannon, Kevin AU - Shannon K FAU - Child, John AU - Child J LA - eng PT - Journal Article PL - United States TA - Congenit Heart Dis JT - Congenital heart disease JID - 101256510 SB - IM MH - Adolescent MH - Adult MH - *Catheter Ablation/adverse effects/mortality MH - Female MH - *Fontan Procedure/adverse effects/mortality MH - Heart Defects, Congenital/mortality/*surgery MH - Heart Ventricles/abnormalities/*surgery MH - Hospital Mortality MH - Humans MH - Los Angeles MH - Male MH - Middle Aged MH - Palliative Care MH - Recurrence MH - Retrospective Studies MH - Risk Assessment MH - Risk Factors MH - Tachycardia, Supraventricular/etiology/mortality/*surgery MH - Time Factors MH - Treatment Outcome MH - Young Adult EDAT- 2010/11/23 06:00 MHDA- 2011/03/05 06:00 CRDT- 2010/11/20 06:00 PHST- 2010/11/20 06:00 [entrez] PHST- 2010/11/23 06:00 [pubmed] PHST- 2011/03/05 06:00 [medline] AID - CHD443 [pii] AID - 10.1111/j.1747-0803.2010.00443.x [doi] PST - ppublish SO - Congenit Heart Dis. 2010 Sep-Oct;5(5):430-4. doi: 10.1111/j.1747-0803.2010.00443.x.